Search research articles
Contact Us
Filters
Showing results (671-680 of 1,177) with videos related to
Page
of 118
Sort By:
Circulation
|
February 3, 2016
Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate Cancer
Nirmanmoh Bhatia, Marilia Santos, Lee W Jones, et al.
BJU International
|
August 30, 2012
Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE)
Matthew J Resnick, Thomas J Guzzo, Janet E Cowan, et al.
Annals of Surgery
|
August 3, 2020
National Variation in Elective Colon Resection for Diverticular Disease
Alexander T Hawkins, Lauren R Samuels, Russell L Rothman, et al.
Archives of Medical Science : AMS
|
August 2, 2021
Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia
Maciej Banach, Niki Katsiki, Gustavs Latkovskis, et al.
Journal of General Internal Medicine
|
December 3, 2014
Gender, race, and variation in the evaluation of microscopic hematuria among Medicare beneficiaries
Jeffrey C Bassett, JoAnn Alvarez, Tatsuki Koyama, et al.
The Journal of Urology
|
October 23, 1997
Effect of cryptorchidism on testicular histology in a naturally cryptorchid animal model
D F Penson, J A Lugg, C Coyne, et al.
Journal of Psychosocial Oncology
|
August 24, 2010
Long-term adjustment of survivors of ovarian cancer treated for advanced-stage disease
Alice B Kornblith, Kristina Mirabeau-Beale, Hang Lee, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
January 12, 2005
Cone damage in patients receiving high-dose irofulven treatment
Michael S Lee, Nisha Gupta, Richard T Penson, et al.
The American Journal of Managed Care
|
November 29, 2017
The influence of provider characteristics and market forces on response to financial incentives
Brock O'Neil, Mark Tyson, Amy J Graves, et al.
The Lancet. Oncology
|
February 17, 2019
Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial
Bertrand Tombal, Fred Saad, David Penson, et al.
Page
of 118
Search research articles
Search
Showing results (671-680 of 1,177) with videos related to
Sort By:
Page
of 118
Circulation
|
February 3, 2016
Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate Cancer
Nirmanmoh Bhatia, Marilia Santos, Lee W Jones, et al.
BJU International
|
August 30, 2012
Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE)
Matthew J Resnick, Thomas J Guzzo, Janet E Cowan, et al.
Annals of Surgery
|
August 3, 2020
National Variation in Elective Colon Resection for Diverticular Disease
Alexander T Hawkins, Lauren R Samuels, Russell L Rothman, et al.
Archives of Medical Science : AMS
|
August 2, 2021
Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia
Maciej Banach, Niki Katsiki, Gustavs Latkovskis, et al.
Journal of General Internal Medicine
|
December 3, 2014
Gender, race, and variation in the evaluation of microscopic hematuria among Medicare beneficiaries
Jeffrey C Bassett, JoAnn Alvarez, Tatsuki Koyama, et al.
The Journal of Urology
|
October 23, 1997
Effect of cryptorchidism on testicular histology in a naturally cryptorchid animal model
D F Penson, J A Lugg, C Coyne, et al.
Journal of Psychosocial Oncology
|
August 24, 2010
Long-term adjustment of survivors of ovarian cancer treated for advanced-stage disease
Alice B Kornblith, Kristina Mirabeau-Beale, Hang Lee, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
January 12, 2005
Cone damage in patients receiving high-dose irofulven treatment
Michael S Lee, Nisha Gupta, Richard T Penson, et al.
The American Journal of Managed Care
|
November 29, 2017
The influence of provider characteristics and market forces on response to financial incentives
Brock O'Neil, Mark Tyson, Amy J Graves, et al.
The Lancet. Oncology
|
February 17, 2019
Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial
Bertrand Tombal, Fred Saad, David Penson, et al.
Page
of 118